Year: 2014
Type: review
Abstract: Human fungal infections have been on the rise in recent years and proved increasingly difficult to treat as a result of the lack of diagnostics, effective antifungal therapies, and vaccines. Most pathogenic fungi do not cause disease unless there is a disturbance in immune homeostasis, which can be caused by modern medical interventions, disease-induced immunosuppression, and naturally occurring human mutations. The innate immune system is well equipped to recognize and destroy pathogenic fungi through specialized cells expressing a broad range of pattern recognition receptors (PRRs). This review will outline the cells and PRRs required for effective antifungal immunity, with a special focus on the major antifungal cytokine IL-17 and recently characterized antifungal inflammasomes.
Authors: R. A. Drummond, S. L. Gaffen, A. G. Hise, G. D. Brown
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Host Defense in Oral Candidiasis, IL-17 Receptor Signaling in the Oral Mucosa, Wellcome Strategic Award for Medical Mycology and Fungal Immunology, IL-23/STAT3-Driven Oral Immune Responses to Candida albicans, C-type lectins in antifungal immunity, G9000067908, Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
OpenAlex ID: W2118968721
